Bank of Montreal
NGNE icon

Bank of Montreal’s Neurogene NGNE Stock Holding History

Bank of Montreal’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-523
Closed -$5.43K – 4056
2022
Q4 		$5.43K Buy
+523
New +$5.4K ﹤0.01% 3832
2022
Q3 		– Sell
-526
Closed -$11 – 4304
2022
Q2 		$11 Buy
+526
New +$12.8K ﹤0.01% 3845
2021
Q2 		– Sell
-107
Closed -$26K – 4503
2021
Q1 		$26K Sell
107
-204
-66% -$52.1K ﹤0.01% 3959
2020
Q4 		$87K Buy
311
+175
+129% +$42.8K ﹤0.01% 3661
2020
Q3 		$34K Sell
136
-44
-24% -$10.7K ﹤0.01% 3589
2020
Q2 		$47K Buy
180
+119
+195% +$31K ﹤0.01% 3475
2020
Q1 		$13K Hold
61
– – ﹤0.01% 3398
2019
Q4 		$15K Hold
61
– – ﹤0.01% 4445
2019
Q3 		$3K Hold
61
– – ﹤0.01% 4613
2019
Q2 		$3K Hold
61
– – ﹤0.01% 4729
2019
Q1 		$3K Hold
61
– – ﹤0.01% 4103
2018
Q4 		$3K Buy
+61
New +$2.97K ﹤0.01% 4266
2018
Q2 		– Sell
-392
Closed -$110K – 4822
2018
Q1 		$110K Buy
+392
New +$108K ﹤0.01% 2916
2017
Q2 		– Sell
-145
Closed -$48K – 4237
2017
Q1 		$48K Sell
145
-1,111
-88% -$390K ﹤0.01% 3095
2016
Q4 		$350K Hold
1,256
– – ﹤0.01% 2260
2016
Q3 		$336K Hold
1,256
– – ﹤0.01% 2233
2016
Q2 		$166K Hold
1,256
– – ﹤0.01% 2565
2016
Q1 		$222K Buy
1,256
+21
+2% +$4.08K ﹤0.01% 2404
2015
Q4 		$308K Sell
1,235
-235
-16% -$61.8K ﹤0.01% 2189
2015
Q3 		$414K Buy
1,470
+1,275
+654% +$294K ﹤0.01% 1950
2015
Q2 		$27K Hold
195
– – ﹤0.01% 3202
2015
Q1 		$32K Buy
+195
New +$39.6K ﹤0.01% 3094

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's NGNE Position: Q1 2023 in Review

Bank of Montreal sold out of Neurogene (NGNE) in Q1 2023, closing a stake of 523 shares — an estimated $5.43K sold.

Bank of Montreal first reported a position in NGNE in Q1 2015 and held it in 22 quarters. The position peaked at $414K in Q3 2015. 39 funds tracked by Wall St. Rank hold NGNE as of Q1 2023.

  • Bank of Montreal reported no remaining Neurogene position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 523 Neurogene shares in Q1 2023, an estimated $5.43K.
  • Bank of Montreal first reported a position in Neurogene in Q1 2015 and held it in 22 quarters.
  • Bank of Montreal's Neurogene position peaked at $414K in Q3 2015.
  • 39 funds tracked by Wall St. Rank held Neurogene as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.